Aktis Oncology Inc <AKTS.O>: Leerink Partners Assumes Coverage With Outperform Rating; Target Price $33
AKTS•Related News
ADTRAN Q2 FY26 non-GAAP EPS drops to $0.03-$0.05; revenue falls to $280-$282 million
ADTN•
Super Micro Computer Inc <SMCI.O>: Needham Raises Target Price to $46 From $40
SMCI•
Soccer-World Cup final draws record 63 million US viewers, signals soccer's mainstream moment
FOXA•
Houthi Red Sea threat would challenge a stretched US military
XLE•
Washington Trust Bancorp Inc <WASH.O>: Piper Sandler Raises Target Price to $41 From $35
WASH•